Skip to content

AI-Guided Left Bundle Branch Area Pacing

A Pilot Study Assessing Outcomes Of Artificial Intelligence-Guided Left Bundle Branch Area Pacing For Cardiac Resynchronization In Heart Failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07206602
Enrollment
224
Registered
2025-10-03
Start date
2026-01-23
Completion date
2027-11-01
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of this study is to compare the effectiveness of AI-guided LBBAP versus conventional LBBAP (not AI-guided) in improving CRT response rates and clinical outcomes.

Interventions

DEVICEAI-assisted Left Bundle Branch Area Pacing

Patients will undergo a Left Bundle Branch Area Pacing (LBBAP) procedure using AI assisted technology

PROCEDURELeft Bundle Branch Area Pacing

Patients will undergo a Left Bundle Branch Area Pacing (LBBAP) procedure

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age: 18 years or older. * Left Ventricular Ejection Fraction (LVEF): \<50% within 6 months prior to enrollment. * QRS Duration: Resting QRS duration ≥ 130 ms on ECG OR anticipated right ventricular pacing \> 40% OR device in place with right ventricular pacing \> 40% within 6 months prior to enrollment. * Medical Therapy: Optimized on guideline-directed medical therapy for heart failure. * AI-ECG probability of low LVEF: \>0.5

Exclusion criteria

* Age less than 18 years old * Inability to follow-up * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
CRT response rateBaseline, 6 monthsCRT response is defined as an absolute increase of \>5% in left ventricular ejection fraction (LVEF) after 6 months of CRT

Secondary

MeasureTime frameDescription
NYHA (New York Heart Association) ClassBaseline, 6 monthsThe New York Heart Association (NYHA) classification will be assessed using the NYHA questionnaire, which evaluates the extent of physical limitations caused by heart failure. This system categorizes patients into one of four classes, with higher classes indicating more severe functional impairment.
Number of Hospitalizations6 monthsNumber of Hospitalizations will be determined by the number of participants that are hospitalized for heart failure.
Number of Deaths6 monthsNumber of patient deaths by any cause
Left Ventricular Linear DimensionsBaseline, 3 monthsLeft Ventricular Linear Dimensions will be measured by an echocardiogram. A lower value indicates better cardiac function.
Left Ventricular Linear VolumeBaseline, 3 monthsLeft Ventricular Linear Volume will be measured by an echocardiogram. A lower value indicates better cardiac function.
Procedural success: LBBAP-conventional armBaselineLBBAP is considered successful if unipolar paced QRS morphology demonstrated a Qr or qR morphology in lead V1 along with any 1 of the following criteria: * Left bundle branch potential * Transition to selective left bundle branch capture or left ventricular septal capture during threshold testing or programmed stimulation * R-wave peak time \<90 ms in V5-V6 * V6-V1 interpeak interval \>44 ms
Procedural success: AI-LBBAP armBaselineProcedural success is defined as improvement in the AI-ECG predicted likelihood of having a low LVEF from greater than 0.5 at baseline to less than 0.5 after LBBAP.
Fluoroscopy timeBaseline, Approximately 30 minutesFluoroscopy time will be determined by the amount of time that fluoroscopy is used to guide the left bundle branch area pacing (an average of 30 minutes)
Total procedure timeBaseline, Approximately 1-2 hoursTotal procedure time will be determined by the start of the LBBAP procedure until completion (an average of 2 hours)
Lead pacing thresholdsBaselineLead pacing thresholds will be measured in Voltage at millisecond.
ImpedanceBaselineImpedance will be measured in Ohms.
Sensing ParametersBaselineSensing Parameters will be measured in mV (milliVolts)

Countries

United States

Contacts

CONTACTJoseph Abdel Messih
mansour.joseph@mayo.edu507-422-3967
PRINCIPAL_INVESTIGATORFatima Ezzeddine

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026